BACTProject reference: 295226
Funded under :
Bioactive compounds from Turkish marine macro organism and associated fungi for EU industries
Total cost:EUR 96 600
EU contribution:EUR 96 600
Call for proposal:FP7-PEOPLE-2011-IRSESSee other projects for this call
Funding scheme:MC-IRSES - International research staff exchange scheme (IRSES)
In recent years, marine natural product bioprospecting has provided key structures and compounds that proved their potential in several fields (human heath, food, cosmetics, veterinary medicine, etc.), particularly as new therepautic agents for a variety of diseases. Most of the marine secondary compounds are still in preclinical or early clinical development process, but some are already on the market, such as cytarabine, or predicted to be approved soon, such as ET743 (YondelisTM).
The marine environment also represents a largely unexplored source for isolation of new microbes (bacteria, fungi, etc) that are potent producers of bioactive secondary metabolites. Therefore, this explains why most of the research on marine natural products is in fact search for useful bioactive compounds. The marine organisms will be collected from Turkish water in geographic range and different ecological habitats under the terms of Convention of Biological Diversity
The aim of the project is to identify new natural marine compounds that can serve as lead structures for new products in EU industries. The target fields are drug discovery and cosmetic industry. This project enables Europe to compete with USA and Japan.
EU contribution: EUR 56 700
06100 TANDOGAN ANKARA
EU contribution: EUR 39 900
Tel.: +49 21181 14163
Fax: +49 21181 11923